medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 10

<< Back Next >>

Ginecol Obstet Mex 2023; 91 (10)

Early HELLP syndrome: a case report

Acuña GDJ, Helena NR
Full text How to cite this article

Language: Spanish
References: 25
Page: 780-787
PDF size: 253.49 Kb.


Key words:

Pre-eclampsia, HELLP syndrome, Haemolysis, Platelets, Maternal morbidity, Maternal mortality, First trimester ultrasound.

ABSTRACT

Background: HELLP syndrome is a severe, life-threatening complication of preeclampsia characterized by hemolysis, elevated liver enzymes and low platelet count. The prevalence of this syndrome is approximately 0.5-0.9% of pregnancies and 10-20% of pregnancies complicated by severe pre-eclampsia.
Clinical case: 25-year-old female patient, originally from Lima, Peru, with no personal or family history. Obstetric and gynecological history: adolescent pregnancy terminated by caesarean section due to pre-eclampsia with severe criteria at 30 weeks, requiring intensive care, with a newborn weighing 1170 grams who has developed with apparent normality. The current pregnancy is 22 weeks, determined by first trimester ultrasound, with no record of antenatal checks. Based on laboratory reports, a diagnosis of pre-eclampsia with criteria of complicated severity and HELLP syndrome was established. Given the rapid and torpid evolution of the disease, it was decided to terminate the pregnancy by caesarean section after transfusion of platelet apheresis. Anatomopathological examination revealed: placenta with accelerated villous maturation, increased perivillous fibrin and foci of old infarction.
Conclusions: HELLP syndrome is a serious complication of pregnancy with high maternal and perinatal morbidity and mortality, especially when it occurs early in pregnancy.


REFERENCES

  1. Abildgaard U, Heimdal K. Pathogenesis of the syndrome ofhemolysis, elevated liver enzymes, and low platelet count(HELLP): a review. Eur J Obstet Gynecol Reprod Biol 2013;166 (2): 117-23. doi: 10.1016/j.ejogrb.2012.09.026

  2. Haram K, Mortensen JH, Nagy B. Genetic aspects of preeclampsiaand the HELLP syndrome. J Pregnancy 2014; 2014:910751. doi: 10.1155/2014/910751

  3. Ott J, Poschalko G, Zeisler H. Severe early onset hemolysis,elevated liver enzyme, and low platelet-syndrome in 2subsequent pregnancies: case report and review of theliterature. Arch Gynecol Obstet 2010; 281 (2): 265-8. doi:10.1007/s00404-009-1176-z

  4. Medhioub Kaaniche F, Chaari A, Turki O, Rgaieg K, BaccouchN, Zekri M, et al. Up-to-date on the HELLP syndrome(Hemolysis, Elevated Liver enzymes and Low Platelets).Rev Med Interne 2016; 37 (6): 406-11. doi: 10.1016/j.revmed.2015.12.009

  5. Lam MTC, Dierking E. Intensive Care Unit issues in eclampsiaand HELLP syndrome. Int J Crit Illn Inj Sci 2017; 7 (3):136-41. doi: 10.4103/ijciis.Ijciis_33_17

  6. Fitzpatrick KE, Hinshaw K, Kurinczuk JJ, Knight M. Riskfactors, management, and outcomes of hemolysis,elevated liver enzymes, and low platelets syndromeand elevated liver enzymes, low platelets syndrome.Obstet Gynecol 2014; 123 (3): 618-27. 10.1097/aog.0000000000000140

  7. Mihu D, Costin N, Mihu CM, Seicean A, Ciortea R. HELLPsyndrome - a multisystemic disorder. J Gastrointestin LiverDis 2007; 16 (4): 419-24. https://pubmed.ncbi.nlm.nih.gov/18193124/

  8. Perez Botero J, Reese JA, George JN, McIntosh JJ. Severethrombocytopenia and microangiopathic hemolyticanemia in pregnancy: A guide for the consulting hematologist.Am J Hematol 2021; 96 (12): 1655-65. https://doi.org/10.1002/ajh.26328

  9. Gaugler-Senden IP, Huijssoon AG, Visser W, Steegers EA, deGroot CJ. Maternal and perinatal outcome of preeclampsiawith an onset before 24 weeks' gestation. Audit in a tertiaryreferral center. Eur J Obstet Gynecol Reprod Biol 2006; 128(1-2): 216-21. doi: 10.1016/j.ejogrb.2005.11.011

  10. Caicedo DA RM, García-Agudelo L, Vargas-Rodríguez LJ.Preeclampsia atípica: a propósito de un caso. Ginecol ObstetMex 2022; 90 (5): 456-60. https://doi.org/10.24245/gom.v90i5.6929

  11. Khalid F, Mahendraker N, Tonismae T. HELLP Syndrome.StatPearls. Treasure Island (FL): StatPearls Publishing; 2023Jan. https://www.ncbi.nlm.nih.gov/books/NBK560615/

  12. Benedetto C, Marozio L, Tancredi A, Picardo E, NardolilloP, Tavella AM, et al. Biochemistry of HELLP syndrome. AdvClin Chem 2011; 53: 85-104. doi: 10.1016/b978-0-12-385855-9.00004-7

  13. Dusse LM, Alpoim PN, Silva JT, Rios DR, Brandão AH, CabralAC. Revisiting HELLP syndrome. Clin Chim Acta 2015; 451(Pt B): 117-20. doi: 10.1016/j.cca.2015.10.024

  14. Sibai BM. The HELLP syndrome (hemolysis, elevated liverenzymes, and low platelets): much ado about nothing? AmJ Obstet Gynecol 1990; 162 (2): 311-6. doi: 10.1016/0002-9378(90)90376-i

  15. Martin JN, Jr., Blake PG, Lowry SL, Perry KG, Files JC,Morrison JC. Pregnancy complicated by preeclampsiaeclampsiawith the syndrome of hemolysis, elevated liverenzymes, and low platelet count: how rapid is postpartumrecovery? Obstet Gynecol 1990; 76 (5 Pt 1): 737-41. doi:10.1097/00006250-199011000-00001

  16. Gestational Hypertension and Preeclampsia: ACOG PracticeBulletin, Number 222. Obstet Gynecol 2020; 135 (6): e237-e60. doi: 10.1097/aog.0000000000003891

  17. Ganzevoort W, Sibai BM. Temporising versus interventionistmanagement (preterm and at term). Best Pract ResClin Obstet Gynaecol 2011; 25 (4): 463-76. doi: 10.1016/j.bpobgyn.2011.01.004

  18. Sibai BM, Barton JR. Expectant management of severepreeclampsia remote from term: patient selection,treatment, and delivery indications. Am J Obstet Gynecol2007; 196 (6): 514.e1-9. doi: 10.1016/j.ajog.2007.02.021

  19. Van Eerden L, Van Oostwaard MF, Zeeman GG, Page-ChristiaensGC, Pajkrt E, Duvekot JJ, et al. Terminating pregnancyfor severe hypertension when the fetus is considered nonviable:a retrospective cohort study. Eur J Obstet Gynecol ReprodBiol 2016; 206: 22-6. doi: 10.1016/j.ejogrb.2016.08.009

  20. Nasa P, Juneja D, Jain R, Nasa R. COVID-19 and hemolysis,elevated liver enzymes and thrombocytopenia syndromein pregnant women - association or causation? World JVirol 2022; 11 (5): 310-20. doi: 10.5501/wjv.v11.i5.310

  21. da Cunha Sobieray NLE, Zanela M, Padilha SL, Klas CF, deCarvalho NS. HELLP syndrome and COVID-19: A minorrevision of a possible new COVID-19-linked HELLP-likesyndrome". Eur J Obstet Gynecol Reprod Biol 2023; 283:90-4. doi: 10.1016/j.ejogrb.2023.02.005

  22. Jung E, Romero R, Yeo L, Gomez-Lopez N, ChaemsaithongP, Jaovisidha A, et al. The etiology of preeclampsia. Am JObstet Gynecol 2022; 226 (2s): S844-s66. doi: 10.1016/j.ajog.2021.11.1356

  23. Pourrat O, Pierre F. Pronostic obstétrical, rénal et vasculaireà long terme dans les suites de la prééclampsie. AnnalesFrançaises d'Anesthésie et de Réanimation 2010; 29 (5):e155-e60. https://doi.org/10.1016/j.annfar.2010.03.016

  24. Kirkpatrick CA. The HELLP syndrome. Acta Clin Belg 2010;65 (2): 91-7. doi: 10.1179/acb.2010.020

  25. Alese MO, Moodley J, Naicker T. Preeclampsia and HELLPsyndrome, the role of the liver. J Matern Fetal Neonatal Med2021; 34 (1): 117-23. doi: 10.1080/14767058.2019.1572737




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2023;91